Norepinephrine kinetics in the rat with tail-suspension-induced central hypervolemia, as a model of cardio-vascular deconditioning.

J Gravit Physiol

Catecholamines Biology Res. Lab, INSERM Unit-337, Broussais Faculty of Medicine, Paris, France.

Published: July 2000

Tail-suspension (TS) in the rat represents an interesting experimental condition to mimic, on Earth, the microgravity-induced cardiovascular deconditioning although the rat's profile of response is partially different from human's. To investigate underlying pathophysiological mechanisms, we have speculated on a decreased activity of the sympathetic system, (sigma S) triggered by the increase of the central venous pressure (CVP) induced by TS. Thus a decreased activity of the sigma S could account, at least partly, for the deconditioning of the cardiovascular system. The sympathetic activity (sigma A) was evaluated through measurement of the norepinephrine (NE) kinetics in rats that were tail-suspended for either 6, 24 or 48 hours. Neither NE spillover rate nor metabolic clearance rate were changed during TS, as compared to control. Thus, TS for a short period of time in the rat is unlikely to trigger a decrease of the sigma A.

Download full-text PDF

Source

Publication Analysis

Top Keywords

norepinephrine kinetics
8
decreased activity
8
activity sigma
8
kinetics rat
4
rat tail-suspension-induced
4
tail-suspension-induced central
4
central hypervolemia
4
hypervolemia model
4
model cardio-vascular
4
cardio-vascular deconditioning
4

Similar Publications

Parkinson's disease (PD) is a chronic neurodegenerative disorder marked by dopaminergic neuron degeneration in the substantia nigra. Emerging evidence suggests vitamin D3 (VD) plays a therapeutic role in PD, but its precise molecular mechanisms remain unclear. This study employed network pharmacology and bioinformatics to identify VD's hub targets and related pathways.

View Article and Find Full Text PDF

This research work was designed to develop efficient Diosgenin (DGN) loaded biodegradable nanoparticles (DGN-NPs) for treating rheumatoid arthritis. The DGN-NPs were synthesized by ionic-gelation method using chitosan as a biodegradable polymer and in-vitro release study was performed followed by kinetics study. DGN-NPs had an average size of 290 nm, zeta potential of +11.

View Article and Find Full Text PDF
Article Synopsis
  • Postprandial hypoglycaemia (PPHG) is a common complication after Roux-en-Y gastric bypass (RYGB) in individuals with a history of type 2 diabetes, often occurring without symptoms.
  • A study of 24 patients showed that PPHG results from an excessive clearance of glucose and hyperinsulinaemia, linked to higher insulin sensitivity and enhanced beta cell function.
  • Those experiencing PPHG had poor hormonal responses to low blood sugar, leading to more frequent and prolonged hypoglycaemia, which affected their eating habits over time.
View Article and Find Full Text PDF

Population Pharmacokinetic Modelling of Norepinephrine in Healthy Volunteers Prior to and During General Anesthesia.

Clin Pharmacokinet

November 2024

Department of Anaesthesiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

Article Synopsis
  • Intraoperation hypotension (IOH) during surgery can have negative effects, leading to the routine use of norepinephrine (NE) to manage blood pressure under general anesthesia, although its pharmacokinetics during such conditions are not well understood.
  • The study aimed to analyze the pharmacokinetics of NE in healthy volunteers in both awake and general anesthesia states, using a step-up dosing method and measuring plasma concentrations.
  • Results indicated that a two-compartment model effectively described NE dynamics, finding that general anesthesia reduced NE clearance by 10%, with weight, age, and session (awake vs. anesthesia) being significant factors affecting its clearance.
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the effectiveness of morphine sulfate nano-controlled release microspheres in alleviating visceral pain caused by tumors in mice models.
  • Researchers used various experimental groups to compare the pain-relief effects of morphine-loaded microspheres with a control group and found significant reductions in pain responses and improved pain thresholds among the treated groups.
  • Results indicated a high drug release rate from the microspheres, and the treatment led to notable changes in neurotransmitter levels in the brain linked to pain perception, with no significant adverse side effects observed.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!